If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
482.80    0.00 (0.00%)
Bid:
0.00
Ask:
503.00
Spread: 19.20 (3.969%)
Market Cap: £2.48b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

£80m contract win with UK MOD

16 Jan 2023 07:00

RNS Number : 7531M
QinetiQ Group plc
16 January 2023
 

News release

QinetiQ Group Plc

£80m contract win with UK MOD

16 January 2023 - QinetiQ Group plc ("QinetiQ" or the "Company") is pleased to announce that it has won an £80m contract with the UK's Ministry of Defence (MOD).  The contract will provide expertise, training and support to accelerate and transform mission data production; this will enable military platforms and personnel, from the UK and its allies, to be better protected in a rapidly changing threat landscape and enhance the performance of our advanced military systems.

 

We will work in partnership with the MOD for a 10-year period on the transformation project, providing a specialist mission data and electronic warfare skills solution alongside training and IT support. This win is a great example of our cyber and information advantage distinctive offering and the strength of our partnering across industry, bringing together extensive experience of electronic warfare, mission data analysis, communication and information services and data-led transformation to achieve operational advantage over our adversaries.

 

James Willis, Chief Executive of UK Intelligence at QinetiQ said:

 

"We are delighted to be selected as the MoD's Industry Partner for mission data. The contract demonstrates how the MoD works closely with industry to build the skills of the future and introduce innovative approaches to enhance mission capability. Our team is harnessing the value delivered by small and medium sized companies and our academic partners. We look forward to working together in partnership with the MoD delivering the next generation of mission data."

 

About QinetiQ

QinetiQ (QQ.L) is a leading science and engineering company operating primarily in the defence and security markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

For further information please contact:

John Haworth, Group Head of Investor Relations:

+44 (0) 7920 545841

Lorna Cobbett, Citigate Dewe Rogerson (Media enquiries):

+44 (0) 7771 344781

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTDBGDBGXBDGXU
Date   Source Headline
16th Jan 20247:00 amRNSQ3 Trading Update and Share Buyback Programme
10th Jan 20245:00 pmRNSDirector/PDMR Shareholding
12th Dec 20232:38 pmRNSDirector/PDMR Shareholding
12th Dec 20232:32 pmRNSDirector Declaration
22nd Nov 20238:29 amRNSHolding(s) in Company
20th Nov 20237:00 amRNS$170m US new business contract win
16th Nov 20237:00 amRNSInterim Results
13th Nov 20239:58 amRNSDirector/PDMR Shareholding
25th Oct 20237:23 amRNSInvestor Seminar
17th Oct 20238:00 amRNSDirector Declaration
11th Oct 20237:00 amRNSSecond Quarter Trading Update
10th Oct 20233:56 pmRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNS$127m contract win in the US (formerly Avantus)
3rd Oct 20237:00 amRNS$84m contract win in the US
28th Sep 20233:24 pmRNSDirector/PDMR Shareholding
12th Sep 20235:54 pmRNSDirector/PDMR Shareholding
31st Aug 20235:03 pmRNS$224m contract win in the US (formerly Avantus)
25th Aug 20232:23 pmRNSDirector/PDMR Shareholding
10th Aug 20234:31 pmRNSDirector/PDMR Shareholding
27th Jul 20234:45 pmRNSDirector/PDMR Shareholding
20th Jul 20232:00 pmRNSResult of AGM
20th Jul 20237:00 amRNSFirst Quarter Trading Update
11th Jul 20235:30 pmRNSDirector/PDMR Shareholding
21st Jun 202312:15 pmRNSDirector/PDMR Shareholding
14th Jun 202310:00 amRNSHolding(s) in Company
12th Jun 20234:00 pmRNSDirector/PDMR Shareholding
12th Jun 20232:00 pmRNSAnnual Financial Report
25th May 20237:00 amRNSResults for the year ended 31 March 2023
10th May 20234:55 pmRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSFourth Quarter Trading Update
12th Apr 202311:35 amRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSQinetiQ announces £259 million renewal of MSCA
30th Mar 20237:00 amRNSQinetiQ Awarded $92.6M Contract
23rd Mar 20235:00 pmRNSDirectorate Change
20th Mar 202310:30 amRNSDirector Declaration
15th Mar 20232:40 pmRNSDirector Declaration
10th Mar 20232:56 pmRNSDirector/PDMR Shareholding
17th Feb 20239:00 amRNSHolding(s) in Company
16th Feb 20237:00 amRNSGary Stewart appointed CEO for Australia Sector
10th Feb 20231:14 pmRNSDirector/PDMR Shareholding
6th Feb 20231:44 pmRNSDirector/PDMR Shareholding
18th Jan 20237:00 amRNSThird Quarter Trading Update
16th Jan 20237:00 amRNS£80m contract win with UK MOD
10th Jan 20233:43 pmRNSDirector/PDMR Shareholding
5th Jan 20232:38 pmRNSDirector Declaration
12th Dec 20225:23 pmRNSDirectorate Change
12th Dec 20221:44 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSCompletion of the acquisition of Air Affairs
23rd Nov 202212:16 pmRNSCompletion of the acquisition of Avantus
10th Nov 202212:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.